Gene Expression Signature Associated with Clinical Outcome in ALK-Positive Anaplastic Large Cell Lymphoma

Overview of attention for article published in Cancers, November 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

twitter: 1 X user

patent: 7 patents

Readers on

mendeley: 10 Mendeley

So far, Altmetric has seen 7 patents that reference this research output.

NTRK fusion molecules and uses thereof

Grant US-12649952-B2

United States of America

09 Jun 2026

ALK and NTRK1 fusion molecules and uses thereof

Grant US-12522873-B2

United States of America

13 Jan 2026

Fusion molecules and uses thereof

Grant US-12378302-B2

United States of America

05 Aug 2025

Methods of treating cholangiocarcinoma

Grant US-12274699-B2

United States of America

15 Apr 2025

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 3 additional patents.